Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AB, ACA, adult, al, albeit, alcohol, amicable, antimicrobial, arisen, ASP, Astaro, bactericidal, Baltic, bearer, Biden, Bilanzgewinn, biocolloid, biologist, blood, brightest, Bulletin, Bundesdatenschutzgesetz, businessman, CAGR, CCPA, Chicago, CJEU, compatibility, concomitant, counteract, dead, deadline, dealt, debate, departure, Dermatest, destination, DNA, dual, dynamic, Efudex, envisioned, epidermal, ethyl, fatal, felt, female, Finland, flagship, forestry, forty, Galenica, Gesetz, grace, gyrase, Haftung, Hanseatic, headcount, Heilmittelwerbegesetz, hinder, hygiene, IIb, immune, incomplete, incremental, influenced, Inline, Insight, Inspector, Interactive, Intershop, IQVIA, isolated, Joseph, Jr, keratinization, KPMG, Linkbase, lockdown, LTI, Ludwig, Lutter, malignant, Malm, mediate, men, middle, mir, missed, mortality, mupirocin, mutate, narrowband, Nordic, NVI, ODV, OIG, online, overturned, Oxford, pattern, payer, pediatric, pension, pharmacovigilance, PhD, pillar, plant, Poet, precautionary, precursor, predecessor, premature, prematurely, Privatbank, progression, proliferate, Quinolonecarboxylic, Quirin, radiation, reaction, reauthorization, reestimated, reevaluated, reintroduction, remote, reopened, Rescue, retransfer, retransferred, reversal, reverse, rewarding, RPI, Russian, Scandinavia, scenario, Schema, sending, sharp, sharply, shorten, Societal, soft, Stewardship, STI, strep, synthetic, Taxonomy, telehealth, tentatively, thatoverall, thrive, Tirbanibulin, top, topoisomerase, uncommon, underway, undiluted, unharmed, unified, unprecedented, unsure, unusual, uptake, urgent, UV, viability, vicinity, video, Vietnam, vitro, wake, Warsaw, wave, weaken, women, XBRL, xepi®, yellowish
Removed:
accrue, acted, adapted, administer, advanced, aim, AktiengesellschaftorAG, Alacare®adhesive, Allergan, Ameluz®and, Ameluz®for, Ameluz®from, Ameluz®in, Ameluz®PDT, Ameluz®to, Ameluz®were, Ameluz®with, announcement, arranged, assuming, Belgium, belief, binominal, bioavailability, Biofrontera®figurative, bleed, blind, Bowen, capitalizing, carcinomain, Caucasian, centrally, CEO, CH, Chipcard, clinically, comfort, commented, concert, constituted, consultation, core, covalently, covenant, cycle, Dawson, deadly, decarboxylase, deeply, Delaware, demonstrating, depressing, depression, determinative, die, division, documented, downturn, DRAM, Dresden, dry, easier, emitted, excluded, explore, extra, familiar, fraction, front, function, globally, gram, grew, HaftungorGmbH, Hapila, hedge, Heptagon, highlight, histidine, histological, IFRIC, IL, immunosuppressed, inactive, incidence, includinginter, incorporate, individually, Infineon, infrared, ingenol, intent, intragroup, Israeli, itchy, journal, Kapital, Kerastick, keratotic, labeled, labelling, laboratory, Lake, Lang, laser, licensee, lodging, Luxembourg, Luxerm®cream, Luxerm®in, manuscript, marketplace, match, matched, mebutate, metabolism, Metvix®are, Metvix®in, moisturize, multicenter, multinational, negotiate, observation, occasion, opposite, orally, Oy, paragraph, penetrate, photosensitizing, pivotal, plaster, Portugal, prophylactic, prospectively, prototype, Qimonda, ranged, rapidly, rejected, rejuvenating, rejuvenation, relied, renew, renewal, repurchase, researched, rounded, scaly, screening, secondary, Semiconductor, sex, Solar, soothe, stability, stratification, subdivided, successive, supersede, survive, sustained, tablet, theproduct, therewith, thicker, tolerability, toxicology, tracked, train, tranchemultiplied, Ubidyne, unattractive, uncompetitive, underestimation, underwriting, unemployment, unstable, upper, urticaria, urticarial, Vector, warming, wherewithal, yield
Filing tables
Filing exhibits
BFFTF similar filings
Filing view
External links
Exhibit 13.2
CERTIFICATION
The certification set forth below is being submitted in connection with Biofrontera AG’s Annual Report on Form 20-F for the fiscal year ended December 31, 2020 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.
Ludwig Lutter, Chief Financial Officer of Biofrontera AG, certifies that, to the best of his knowledge:
1. | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and | |
2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Biofrontera AG. |
Date: April 12, 2021
/s/ Ludwig Lutter | ||
Name: | Ludwig Lutter | |
Chief Financial Officer |